Viewing StudyNCT00375752



Ignite Creation Date: 2024-05-05 @ 5:01 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00375752
Status: TERMINATED
Last Update Posted: 2017-06-26
First Post: 2006-09-11

Brief Title: Efficacy and Safety of Letrozole vs Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Breast Neoplasms
Keywords:
Name View
Breast cancer View
Anti tumor potential View
Letrozole View
Zoledronic acid View
Neoadjuvant treatment View
Hormone responsive breast cancer View